Al Hammadi Company for Development and Investment (Al Hammadi) announces the awarding of a SAR 347 million contract to Pharma Serve, a wholly-owned subsidiary of Medical Support Services Company (a fully owned subsidiary of Al Hammadi) for a period of 24 months, in relation to the main unified procurement tender for vaccines to all participating government health authorities for the year 2018G, according to the award letter received from the National Unified Procurement Company (NUPCO) dated 13 shaban 1439H, corresponding to 29 april 2018G. Al Hammadi will announce in due course any further developments including the official signing of the contract.The financial impact of this project is expected to start in the third quarter of the fiscal year 2018G.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.